Tectonic Therapeutic | AVRO - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Akebia Therapeutics USD 155.55M 7.1M 2026-06
Alnylam Pharmaceuticals USD 1.71B 2.46M 2026-06
Celltrion KRW 56.79B 6.92B 2026-03
Cspc Pharmaceutical CNY 6.09B 1.48B 2025-12
Deva Holding AS TRY 775.92M 574.67M 2023-09
Dianthus Therapeutics USD 110.55M 517.12M 2026-06
Divis Laboratories Ltd INR 1.28B 2.87B 2026-03
Gilead Sciences USD 7.63B 64M 2026-03
Ionis Pharmaceuticals USD 350.06M 1.57B 2026-06
Kangmei Pharma CNY 1.23B 48.16M 2026-03
Karyopharm Therapeutics USD 90.85M 30.31M 2026-03
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Laboratorios Farma EUR 46.11M 18.92M 2025-06
MacroGenics USD 113.91M 47.39M 2026-06
Malin Corporation EUR 62.1M 26.4M 2024-12
Medical Developments International AUD 17.84M 219K 2025-06
Neuren Pharmaceuticals AUD 4.23M 1.68M 2025-12
Organigram Holdings CAD 4.29M 3.28M 2026-03
Pfizer USD 976M 727M 2026-06
Pharma Mar EUR 19.34M 29.53M 2026-06
Qiagen NV USD 646.29M 192.72M 2026-03
Roche Holding CHF 7.55B 579M 2025-06
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Sanofi EUR 6.35B 806M 2026-06
Sarepta Therapeutics USD 571.15M 106.7M 2026-06
Sartorius EUR 291M 282.8M 2026-06
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
Takeda JPY 460.98B 134.07B 2026-06
Tilray USD 264.83M 43.16M 2025-06
Zealand Pharma A/S 3.85B 727.54M 2026-03
Zz Pientze Pharmaceu CNY 1.96B 186.63M 2026-03